Merck (NYSE:MRK) plans to present more than 100 oncology abstracts at the 2026 ASCO Annual Meeting. The company will share ...

Terns is now a wholly-owned subsidiary of Merck and its stock will no longer be listed or traded on the Nasdaq Global Select ...

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing therapies across oncology, immunology, and diabetes and cardiovascular areas.

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration shows Merck logo (Reuters) -Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the ...

Three hours inland from Chennai, India, traffic crawls on a half-finished road past rice fields and cow crossings until it reaches a newer complex of neat white buildings. Among them is the cancer ...

By Sabrina Valle NEW YORK, April 22 (Reuters) - Inhibrx Biosciences has drawn interest from drugmakers including Merck & Co, Germany’s Merck KGaA and Japan's Ono Pharmaceutical for an experimental ...

Add Yahoo as a preferred source to see more of our stories on Google. A wall showing a Merck & Co. logo in Kenilworth, New Jersey (Courtesy of Merck & Co.) This story was originally published on ...

While the fianlimab arm showed a numerical improvement in progression-free survival, the difference was not statistically ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head ...

Merck & Co., Inc. (NYSE:MRK) is a global health care company working to deliver innovative health solutions through our ...